1. Home
  2. INSG vs COYA Comparison

INSG vs COYA Comparison

Compare INSG & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$6.64

Market Cap

144.4M

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.28

Market Cap

124.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
COYA
Founded
1996
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.4M
124.8M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
INSG
COYA
Price
$6.64
$4.28
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$15.33
$15.80
AVG Volume (30 Days)
241.9K
266.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$313,832,000.00
$7,945,753.00
Revenue This Year
$16.21
N/A
Revenue Next Year
$13.28
$763.10
P/E Ratio
$10.89
N/A
Revenue Growth
N/A
123.57
52 Week Low
$6.28
$3.71
52 Week High
$21.90
$7.75

Technical Indicators

Market Signals
Indicator
INSG
COYA
Relative Strength Index (RSI) 23.12 33.98
Support Level N/A $3.90
Resistance Level $12.95 $5.18
Average True Range (ATR) 0.45 0.34
MACD -0.01 -0.12
Stochastic Oscillator 0.45 2.99

Price Performance

Historical Comparison
INSG
COYA

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: